Frazier Life Sciences Management, L.P. - GRACELL BIOTECHNOLOGIES INC ownership

GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 34 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of GRACELL BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2022$9,306,000
-45.6%
2,890,102
-7.1%
0.72%
-55.6%
Q2 2022$17,114,000
+113.2%
3,111,551
-9.7%
1.62%
+136.1%
Q1 2022$8,029,0003,445,9730.68%
Other shareholders
GRACELL BIOTECHNOLOGIES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 2,890,102$9,306,0000.72%
Orbimed Advisors 7,884,870$25,389,0000.47%
GREAT POINT PARTNERS LLC 449,049$1,446,0000.35%
Vivo Capital, LLC 961,359$3,096,0000.34%
Capital International, Inc./CA/ 3,016,371$9,713,0000.22%
Temasek Holdings (Private) Ltd 9,901,940$31,884,2470.19%
EcoR1 Capital, LLC 1,921,310$6,187,0000.18%
Capital International Sarl 304,582$981,0000.08%
FEDERATED HERMES, INC. 1,298,578$4,181,0000.01%
Cannell Capital 14,299$46,0000.01%
View complete list of GRACELL BIOTECHNOLOGIES INC shareholders